Roots Analysis

MARCH 1, 2024

Examples of such technologies include DNA Taggants (a unique DNA tag used in the product / packaging that can be scanned using a designated instrument / equipment), invisible printing technologies, digital watermark technologies and hidden markers / print technologies.

Packaging 52

Packaging Packaging Production Manufacturing 52

XTalks

APRIL 18, 2024

However, Roche has several CSF tests on the market, which include assays in the company’s Elecsys line that are used in conjunction with PET in the diagnosis and monitoring of the disease. There are currently no FDA-authorized blood tests for detecting Alzheimer’s disease.

Clinical Trials 52

Clinical Trials Clinical Trials In-Vitro Protein 52

Pharmaceutical Technology

APRIL 5, 2023

More than a decade after the first patient was treated with a CAR-T therapy, six therapies relying on the same principles have been approved by the US Food and Drug Administration (FDA) and marketed to thousands of patients. AZ: What is the ISCT doing to tackle supply and access-related obstacles in the CAR-T field?

Gene Therapy 147

Gene Therapy Gene Engineer Production 147

pharmaphorum

JANUARY 24, 2022

IBM said the sell-off is tagged as “a clear next step” as it focuses on its platform-based hybrid cloud and artificial intelligence strategy, but it’s no secret that Watson Health has failed to live up to its early promise.

Radiology 110

Radiology Marketing Genome Genomics 110

Drug Discovery World

JANUARY 30, 2024

However, I believe we should focus foremost on getting approved therapies to the market so patients have options.” Heather Purvis, Director of Clinical Operations, Title21 Health Solutions, said that as advanced therapies and approaches to patient care continue to evolve, the need for standardised and turnkey approaches grows.

Gene Therapy 71

Gene Therapy Manufacturing Gene Clinical Trials 71

pharmaphorum

SEPTEMBER 15, 2020

As pharmaceutical marketers prepare their brands for the future, there are a number of important ways they can learn from digitally-native brands. This is reinforced by web-focused marketing strategies that give them a highly-targeted approach when it comes to marketing execution.”. Be more agile .

Branding 129

Branding Marketing Pharma Companies Life Science 129

Rethinking Clinical Trials

JULY 6, 2023

Over the past several years, a variety of factors have accelerated the need for decentralized trials, including the push to make trials more accessible, the increased speed of science, the possibility of environmentally conscious trials, and the need to be flexible in a rapidly changing world.

Trials 130

Trials Clinical Trials Clinical Trials Licensing 130

pharmaphorum

JANUARY 21, 2022

Access to medicines is “one of the most challenging policy areas in every country in the European region” – it’s time to develop a solution that works for everyone. Balancing the incentivisation of innovation against affordable access to revolutionary new medicines is an age-old conundrum in the biopharmaceutical industry.

Medicine 52

Medicine Marketing Manufacturing Production 52

pharmaphorum

AUGUST 17, 2020

N o one industry is ever quite like another, but there are some valuable lessons for pharma marketing from examining how the financial sector uses technology, builds brands on social channels and approaches digital content. Engagement channels. Joanna Carlish.

Regulation 97

Regulation Marketing Sales Branding 97

pharmaphorum

APRIL 20, 2021

NICE’s final appraisal document for Kesimpta will be followed by technology appraisal guidance (TAG) that will pave the way for NHS prescribing in England and Wales. The Scottish Medicines Consortium is expected to publish its final advice on the drug later this year. billion by 2028. billion in sales in 2028.

Sales 110

Sales Medicine Drugs Marketing 110

Rethinking Clinical Trials

FEBRUARY 28, 2024

The global decentralized clinical trial market is expected to grow at a compound annual growth rate of 30.1% Tags #pctGR, @Collaboratory1 The post Grand Rounds February 23, 2024: Virtual Vigilance: Monitoring of Decentralized Clinical Trials (Adrian Hernandez, MD; Christopher J. from 2021 to 2026.

Clinical Trials 141

Clinical Trials Clinical Trials Trials Clinical Research 141

Intouch Solutions

APRIL 11, 2024

Precision engagement is a data-driven approach developed for marketing and sales needs. Offering the physician support from a virtual assistant during the differential diagnosis process where they have access to a more extensive knowledge and experience base. So, what is precision engagement?

Compliance 52

Compliance Marketing Drugs Pharma Companies 52

Drug Discovery World

MAY 22, 2023

Large pharma involvement in advanced therapies has seen ebbs and flows, with AstraZeneca taking a larger stake in the market and Takeda developing its automation and digital capabilities, but also with GSK letting go of its CGT projects, along with most of the staff involved in its R&D. But are these price tags a barrier to access?

Gene Therapy 52

Gene Therapy Gene Drugs Contamination 52

XTalks

JULY 12, 2021

Experts like Bernstein analyst Ronny Gal said it was an “almost shockingly broad” label that would give Biogen unwarranted market access to the approximately 6 million Alzheimer’s sufferers in the US. On the other hand, Biogen is being aggressively questioned over its tacking on of such a hefty price tag for the drug.

Drugs 98

Drugs Clinical Trials Clinical Trials Trials 98

Roots Analysis

JANUARY 28, 2024

Velocity: Big Data needs to be handled promptly as businesses generate data at an unprecedented speed, driven by the growing adoption of Internet of Things (IoT), and technologies, such as RFID tags, sensors, and smart meters are used to deal with the high velocity of data in real-time. It is loosely arranged into categories using meta tags.

Big Data 40

Big Data Medicine Marketing Clinical Trials 40

pharmaphorum

JUNE 8, 2021

Instead, the FDA granted Aduhelm a conditional approval, allowing it to be prescribed and used while Biogen conducts a post-marketing, phase 4 confirmatory study – which could take years to complete. AA provides earlier patient access to a promising treatment but requires sponsors to conduct an additional trial to verify benefit.

Drugs 98

Drugs Marketing FDA Approval Trials 98

pharmaphorum

JANUARY 11, 2021

US biotech bluebird bio has announced plans to split into two this year, with a separate oncology business spinning off as the company prepares to bring its products to market. Zynteglo is already in beta-thalassemia in Europe, where the company will seek to expand access despite its hefty $1.8 million price tag.

Gene Therapy 63

Gene Therapy Gene Genetic Disease Manufacturing 63

Pharmaceutical Technology

MARCH 22, 2023

The pharmaceutical industry began using radio frequency identification (RFID) tags in the early 2000s. Pfizer was the first to use the tech, adding RFID tags to track a Viagra (sildenafil) shipment circa 2006. Twenty years ago, the cost of implementing RFID tags and the ecosystem (software) was much more expensive than today.

Production 264

Production Pharma Production Pharma Companies Drugs 264

Delveinsight

JULY 22, 2020

The method of services delivery and design has transformed to the extent that people can access healthcare services from thousands of miles away with just a smartphone. Now the user can easily access the information through various user interfaces for their personal, commercial or industrial decision making as required.

Doctors 59

Doctors Doctor Marketing Production 59

pharmaphorum

NOVEMBER 16, 2022

Only a few years later, bluebird bio’s gene therapy, Zynteglo (betibeglogene autotemcel), was approved in the European market for the treatment of the rare blood disorder, beta thalassaemia. However, with a price tag of €1.58 Equity of access. How to navigate the new climate. At more than $2.1

Gene Therapy 131

Gene Therapy Gene Marketing Development 131

Intouch Solutions

AUGUST 25, 2021

While this is a big step in the ongoing movement toward protecting consumer privacy, there is increased attention to its impact on email marketing. What started as a move to protect personal data and privacy from Big Tech has grown into a larger initiative placing consumers at the center of owning their experience and controlling data access.

Marketing 52

Marketing Regulation Engineer Branding 52

Pharmaceutical Technology

JANUARY 27, 2023

Jakub Hlávka, PhD, the executive director of the Healthcare Markets Initiative and Fellow at the University of Southern California Schaeffer Center, suggests the strategy behind this new warranty program could “minimise the [financial and clinical] risk for the provider and for the patient”.

Manufacturing 130

Manufacturing Drugs Research Analyst FDA Approval 130

XTalks

FEBRUARY 27, 2024

Despite high price tags of a couple of million dollars, gene therapy makers say they are working to ensure patients are able to access the treatments through patient assistance programs developed in conjunction with the support of governments. Sarepta hopes to clarify Elvidys’ effectiveness in older children in a confirmatory trial.

Research 59

Research Drugs Gene Therapy Clinical Trials 59

pharmaphorum

JUNE 15, 2021

Can the biopharma industry step up again to shatter industry orthodoxy and create new pathways for innovation, access, and affordability? Consider that the cost of bringing a successful treatment to market – including the cost of capital and cost of failure – is between $2.6 New Science is clearly on the rise. billion and $6.7

Clinical Trials 90

Clinical Trials Clinical Trials Development Marketing 90

XTalks

AUGUST 23, 2021

But these aims must be balanced with the third principle of protecting study participants from unnecessary risks, like those that may result from preventing patients from accessing available therapies to maintain the integrity of the treatment and placebo arms of the trial.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Drugs 52

Cloudbyz

JUNE 1, 2023

Granular Security & Access Control Salesforce provides robust security and access control features, designed to help organizations secure their data while still providing necessary access to users. These features ensure that only authorized users can access certain data and perform specific actions.

Compliance 87

Compliance Development Branding Production 87

The Pharma Data

NOVEMBER 15, 2020

Cytiva provides FlexFactory bioprocessing upstream and downstream solutions for Clover to accelerate GMP facility development and shorten time to market. Clover aims to double its commercial manufacturing capacity in preparation for global Phase 2/3 trials. SHANGHAI , Nov.

Vaccination 52

Vaccination Vaccine Manufacturing Life Science 52

XTalks

AUGUST 19, 2022

XTALKS WEBINAR: How Agile Clinical Trials Unlock Universal Access to Rare Disease Research. Zynteglo’s hefty price tag of $2.8 Live and On-Demand: Tuesday, October 4, 2022, at 11am EDT (4pm BST/UK). Although the therapy is administered to the patient once, the treatment process has several steps that may take place over several months.

Gene Therapy 95

Gene Therapy FDA Approval Gene Clinical Trials 95

Intouch Solutions

JULY 27, 2021

And 17%, or 56 million Americans, can be considered “medically disenfranchised,” with inadequate access to a primary care doctor. In the case of aducanumab, it was developed through traditional processes and will be priced traditionally at, as they put it, “whatever the market will bear.” In the case of the vaccines, the U.S.

Drugs 52

Drugs Marketing Vaccination Vaccine 52

The Pharma Data

MAY 15, 2021

While this was unfortunate for the soldiers as they lost access to an excellent tool that helped them lose weight and stay fit… This is fortunate for you because it’s allowed us to create our PentagonFit tracker – and give them away– for just the cost of shipping. Most people don’t know it, but U.S

Production 52

Production Containment Medicine Vaccination 52

XTalks

MARCH 22, 2023

And make sure you’re registered for our free online community for instant access to thousands of on-demand webinars. In addition, nearly half of all new drugs launched between 2020 and 2021 came with a price tag of $150,000 per year, or more. The pharmaceutical industry has seen tremendous change in the past 20 years.

Life Science 97

Life Science Drugs FDA Approval Vaccination 97

Drug Discovery World

NOVEMBER 13, 2023

The track will be opened by chairperson remarks from Daniel Chen, MD, PhD, Founder, Engenuity Life Sciences, which will be followed by the track’s keynote presentation by Bent Jakobsen, PhD, FMedSci, CEO & Founder, Accession Therapeutics. It is called, ‘An unexpected future for immune oncology therapies?’

Protein 59

Protein Antibody Engineer Scientist 59

The Pharma Data

MAY 4, 2021

Following the completion of the spin-off of the Upjohn Business (4) in the fourth quarter of 2020, Pfizer now operates as a focused innovative biopharmaceutical company engaged in the discovery, development, manufacturing, marketing, sales and distribution of biopharmaceutical products worldwide. in December 2019; and.

Vaccination 40

Vaccination Vaccine Production Sales 40

Pharmaceutical Technology

MARCH 17, 2023

These agreements have been particularly propelled by the recent rise in inflationary pressures and pharmaceutical market instability, pushing healthcare systems to find new ways to reduce risks associated with new drugs. Thus, a higher risk score reflects a more hostile market access environment and drug launch in a geographical area.

Marketing 257

Marketing Drugs Research Analyst Manufacturing 257

Pharmaceutical Technology

NOVEMBER 30, 2022

According to GlobalData, as of November 28, there were 316 generic and novel drugs marketed to treat obesity. The company’s weight loss drug Saxenda (liraglutide) won an approval for chronic weight management in December 2014, and Wegovy (semaglude) got the same tag in 2021. Access to anti-obesity medications. million in Q3.

Drugs 264

Drugs Manufacturing Hormones Contract Manufacturing 264

Pharmaceutical Technology

NOVEMBER 30, 2022

According to GlobalData, as of November 28, there were 316 generic and novel drugs marketed to treat obesity. The company’s weight loss drug Saxenda (liraglutide) won an approval for chronic weight management in December 2014, and Wegovy (semaglude) got the same tag in 2021. Access to anti-obesity medications. million in Q3.

Drugs 246

Drugs Manufacturing Hormones Contract Manufacturing 246

Pharma Marketing Network

JUNE 8, 2020

This is Don Langsdorf with the Pharma Marketing Network pleased to welcome today Dave Chase, co-founder of the Health Rosetta. There’s what I call the real market and so this market really exploded, and I have data in this chapter about it. In that market, the real Market, my view prices have been flat for 5 to 10 years.

HR 40

HR Marketing Doctors Doctor 40